Art

J-GLOBAL ID：201702254589458461   Reference number：17A0519264

Relationship between dose of antithyroid drugs and adverse events in pediatric patients with Graves’ disease

Graves病の小児患者における抗甲状腺薬の用量と有害事象の関連

Author (10)： Yasuda Kie (Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Miyoshi Yoko (Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Tachibana Makiko (Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Namba Noriyuki (Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Namba Noriyuki (Department of Pediatrics, Japan Community Health Care Organization Osaka Hospital, Osaka, Japan) ,  Miki Kazunori (Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Miki Kazunori (Department of Pediatrics, Itami Municipal Hospital, Hyogo, Japan) ,  Nakata Yukiko (Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Takano Toru (Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan) ,  Ozono Keiichi (Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan)
Material： Clinical Pediatric Endocrinology  (Clin Pediatr Endocrinol)
Volume： 26  Issue： 1  Page： 1-7(J-STAGE)  Publication year： 2017 
JST Material Number： L4217A  ISSN： 0918-5739  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0519264&from=J-GLOBAL&jstjournalNo=L4217A") }}

Author keywords (5)： Graves’ disease ,  children ,  antithyroid drug ,  methimazole ,  adverse event

JST classification (2)： Drug therapy(=pharmacotherapy)for endocrine diseases  (GL05020S) ,  Clinical application of drugs acting on endocrine system and genital organ  (GW10020V)

Substance index (1)： Methimazole

Reference (17)：

• 1. Rivkees, SA. The treatment of Graves disease in children. J Pediatr Endocrinol Metab 2006;19: 1095-111.
• 2. Rivkees, SA, Sklar, C, Freemark, M. Clinical review 99: The management of Graves disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998;83: 3767-76.
• 3. Japanese Society for Pediatric Endocrinology2008 Guideline for the drug treatment of childhood onset Graves’ disease. Nippon Shonika Gakkai Zasshi 2008;112: 946-52 (In Japanese).
• 4. Japan Thyroid Association 2011 Guideline for the drug treatment of Graves’ diseases. 1st ed. Tokyo: Nankodo; 2011. p. 135-140.
• 5. Japanese Society for Pediatric Endocrinology2016 Guideline for the treatment of childhood onset Graves’ disease. http://jspe.umin.jp/medical/files/gravesdisease_guideline2016.pdf. (accessed: April 23, 2016).

Terms in the title (5)： Graves病 ,  小児患者 ,  抗甲状腺薬 ,  用量 ,  有害事象